OverviewSuggest Edit

iVexSol is a viral vector manufacturing company. Its technology aims to reduce the complexity, cost and development time of critical reagents, thereby accelerating the development and enabling access to cell and gene therapies for CGT researchers and manufacturers.

iVexSol Financials and Metrics

Summary Metrics

Founding Date


iVexSol total Funding

$2 m

iVexSol latest funding size

$2 m

Time since last funding

5 months ago

iVexSol investors

iVexSol's latest funding round in September 2019 was reported to be $2 m. In total, iVexSol has raised $2 m
Show all financial metrics

iVexSol Online and Social Media Presence

Embed Graph

iVexSol Frequently Asked Questions

  • When was iVexSol founded?

    iVexSol was founded in 2019.

  • Who are iVexSol competitors?

    Competitors of iVexSol include DegenRx, apceth Biopharma and Gyroscope Therapeutics.